Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1989-6-1
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0271-0749
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
73
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2708563-Antidepressive Agents, Tricyclic,
pubmed-meshheading:2708563-Depressive Disorder,
pubmed-meshheading:2708563-Drug Therapy, Combination,
pubmed-meshheading:2708563-Humans,
pubmed-meshheading:2708563-Lithium,
pubmed-meshheading:2708563-Prognosis,
pubmed-meshheading:2708563-Triiodothyronine
|
pubmed:year |
1989
|
pubmed:articleTitle |
What is the duration for augmentation with T3 or lithium in resistant depression?
|
pubmed:publicationType |
Letter
|